Journal
ANNALS OF ONCOLOGY
Volume 23, Issue -, Pages 86-91Publisher
OXFORD UNIV PRESS
DOI: 10.1093/annonc/mds229
Keywords
-
Categories
Funding
- AstraZeneca
- Novartis
- Cephalon
- Merck Sharp Dohme
- Transgene
- Bristol-Myers Squibb
- Roche
- GlaxoSmithKline
- Bayer